Bucks County, Pa. has initiated legal proceedings against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated effort to inflate ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...

Bucks County has joined municipalities across the nation in suing major insulin manufacturers and drug price negotiating ...

In its lawsuit against several healthcare giants, the county contends insulin costs jumped more than 1,000 percent, with medications that cost manufacturers approximately $2 per vial to produce ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...